Eye News and Research

Latest Eye News and Research

Researchers develop set of tools that may help diabetic patients and their docs to manage condition

Diabetes affects around 10% of the population; according to the World Health Organisation (WHO). The disease places a huge financial burden on healthcare systems, and also leads to early death and poor quality of life. However, patients and healthcare professionals will now be able to partner up and manage the illness in better, more effective ways.

22 May 2014

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

AbbVie announced today that the U.S. Food and Drug Administration has granted HUMIRA orphan drug designation for the treatment of non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis, a group of rare but serious inflammatory diseases of the eye.

21 May 2014

Optegra top tips for healthy eyes this hayfever season

This year's hayfever season is upon us: the temperatures and pollen count start to rise, noses are beginning to run and eyes are starting to itch.

20 May 2014

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Following a May 15, 2014, meeting with the U.S. Food and Drug Administration (FDA), Shire plc, the global specialty biopharmaceutical company, announces today that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as we complete remaining chemistry and manufacturing work.

19 May 2014

Research reports on Asian cosmetic surgery market

MarketReportsOnline.com offers "Cosmetic Surgery Market in Asia" 2014 industry research report, on South Korea, Thailand, India and Singapore, in its store.

19 May 2014

Bacteria in urine may be associated with overactive bladder

Contrary to popular belief, urine is not sterile and the bacteria in it may be associated with overactive bladder (OAB) in some women, according to research presented today at the annual meeting of the American Society for Microbiology.

19 May 2014

$Fracture liaison service reduces risk of fragility fractures in older adults$

Fracture liaison service reduces risk of fragility fractures in older adults

Studies have shown that anyone age 50 or older who suffers a fragility fracture – a bone break sustained in a fall from a standing height or less – is two to five times more likely to experience a second fracture than someone who hasn't had one. The odds that a person who's suffered two such fractures will have a third are even higher.

17 May 2014

Researchers develop potential route to new therapies for treatment of Parkinson's disease

A biologist and a psychologist at the University of York have joined forces with a drug discovery group at Lundbeck in Denmark to develop a potential route to new therapies for the treatment of Parkinson's Disease (PD).

16 May 2014

NovaBay completes enrollment of patients in global Phase 2b viral conjunctivitis trial

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing non-antibiotic, topical antimicrobial products, today announced it has completed enrollment of patients in its global Phase 2b viral conjunctivitis trial, BAYnovation.

16 May 2014

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

Eleven Biotherapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today reported financial results and operational highlights for the quarter ended March 31, 2014.

15 May 2014

Global scientists to discuss latest findings on diagnosis, causes and treatments of ASD

The International Society for Autism Research (INSAR), a scientific and professional organization devoted to advancing knowledge about autism spectrum disorders, convened more than 1700 researchers, delegates, autism specialists and students from 40 countries for the 13th Annual International Meeting for Autism Research (IMFAR), the world's largest scientific gathering on autism research, from May 15 through May 17 at the Atlanta Marriott Marquis in Atlanta, GA.

15 May 2014

Astellas reports efficacy, safety data of isavuconazole invasive aspergillosis SECURE study at ECCMID

Astellas reported today that the efficacy and safety data of the isavuconazole invasive aspergillosis study (SECURE) were presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Barcelona, Spain.

15 May 2014

Safety tips to prevent injuries associated with lawn mowers

The lawn mower is one of the most dangerous household tools. According to the American Academy of Pediatrics, each year 68,000 people are treated in the emergency department for lawn mower related injuries, and 9,400 of them are children under the age of 18.

15 May 2014

Researchers develop chip-like device to sort, store and retrieve individual living cells for study

A U.S. and Korean research team has developed a chip-like device that could be scaled up to sort and store hundreds of thousands of individual living cells in a matter of minutes. The system is similar to a random access memory chip, but it moves cells rather than electrons.

14 May 2014

Scientists find protein that controls DNA organization during sperm development

Infertility is generally thought of as a woman's problem. In fact, more than 3 million men across America also experience it.

13 May 2014

Amakem commences Phase 2 dose-ranging study of AMA0076 drug for treatment of glaucoma

Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma.

13 May 2014

Study reveals 70% of patients with diabetic retinopathy will develop macular edema

In Mexico, at least 14 million people have developed macular edema due to diabetes (DME), which like retinopathy affects central vision and can lead to blindness if not treated early .

13 May 2014

Molecular imaging and multimodality: an interview with Professor Silvio Aime, University of Turin

Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.

From Bruker BioSpin - NMR, EPR and Imaging 12 May 2014

Research roundup: Unearthing factors in hospital readmissions; dissecting the enrollment surge

Using inpatient data from an urban teaching hospital, we examined how elements of individual characteristics and neighborhood socioeconomic status influenced the likelihood of readmission ... Patients living in high-poverty neighborhoods were 24 percent more likely than others to be readmitted, after demographic characteristics and clinical conditions were adjusted for. Married patients were at significantly reduced risk of readmission, which suggests that they had more social support than unmarried patients. These and previous findings that document socioeconomic disparities in readmission raise the question of whether CMS's readmission measures and associated financial penalties should be adjusted for the effects of factors beyond hospital influence at the individual or neighborhood level, such as poverty and lack of social support (Hu, Gonsahn and Nerenz, May 2014).

12 May 2014

New drug approach for safer clean-up of deformed blood vessels in eye

A new drug approach has been developed for safer clean-up of deformed blood vessels in the eye by a research team at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto.

12 May 2014

Eye News and Research

Latest Eye News and Research

Researchers develop set of tools that may help diabetic patients and their docs to manage condition

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

Optegra top tips for healthy eyes this hayfever season

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Research reports on Asian cosmetic surgery market

Bacteria in urine may be associated with overactive bladder

Fracture liaison service reduces risk of fragility fractures in older adults

Researchers develop potential route to new therapies for treatment of Parkinson's disease

NovaBay completes enrollment of patients in global Phase 2b viral conjunctivitis trial

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

Global scientists to discuss latest findings on diagnosis, causes and treatments of ASD

Astellas reports efficacy, safety data of isavuconazole invasive aspergillosis SECURE study at ECCMID

Safety tips to prevent injuries associated with lawn mowers

Researchers develop chip-like device to sort, store and retrieve individual living cells for study

Scientists find protein that controls DNA organization during sperm development

Amakem commences Phase 2 dose-ranging study of AMA0076 drug for treatment of glaucoma

Study reveals 70% of patients with diabetic retinopathy will develop macular edema

Molecular imaging and multimodality: an interview with Professor Silvio Aime, University of Turin

Research roundup: Unearthing factors in hospital readmissions; dissecting the enrollment surge

New drug approach for safer clean-up of deformed blood vessels in eye

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Eye News and Research

Latest Eye News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in